Plus Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1998
Revenue	4.91	0.22	0	0.3	7	2.98	6.41	11.38	11.66	7.6	Upgrade
Revenue Growth (YoY)	2093.30%	-	-	-95.67%	134.60%	-53.47%	-43.66%	-2.39%	53.45%	-37.70%	Upgrade
Cost of Revenue	0	0	0	0	0	0	1.32	2.17	3.19	2.94	Upgrade
Gross Profit	4.91	0.22	0	0.3	7	2.98	5.09	9.21	8.47	4.66	Upgrade
Selling, General & Admin	8.54	10.24	6.85	6.41	5.29	6.22	11.19	12.17	12.43	22.36	Upgrade
Research & Development	9.69	9.7	5.32	2.7	5.37	5.52	11.68	16.2	19	15.11	Upgrade
Other Operating Expenses	0	0	0.32	0.78	0	0	1.69	0	0	0	Upgrade
Operating Expenses	18.23	19.94	12.49	9.89	10.66	11.75	24.55	28.37	31.43	37.46	Upgrade
Operating Income	-13.32	-19.71	-12.49	-9.58	-3.66	-8.76	-19.46	-19.16	-22.95	-32.81	Upgrade
Interest Expense / Income	0.4	0.71	0.93	1.11	1.86	1.92	2.05	2.59	3.38	4.37	Upgrade
Other Expense / Income	-0.4	-0.15	-0.03	-2.45	5.38	1.95	1.18	0.29	-7.59	0.19	Upgrade
Pretax Income	-13.32	-20.28	-13.4	-8.24	-10.89	-12.63	-22.69	-22.05	-18.74	-37.37	Upgrade
Net Income	-13.32	-20.28	-13.4	-8.24	-10.89	-12.63	-22.69	-22.05	-18.74	-37.37	Upgrade
Preferred Dividends	0	0	0	0	0.55	2.49	3.98	0	0.66	1.17	Upgrade
Net Income Common	-13.32	-20.28	-13.4	-8.24	-11.44	-15.12	-26.66	-22.05	-19.41	-38.54	Upgrade
Shares Outstanding (Basic)	3	2	1	0	0	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	3	2	1	0	0	0	0	0	0	0	Upgrade
Shares Change	79.45%	117.07%	173.03%	219.93%	696.08%	168.36%	87.30%	84.27%	74.13%	19.24%	Upgrade
EPS (Basic)	-4.24	-11.58	-16.64	-27.89	-123.99	-1304.05	-6169.41	-9595.20	-15517.24	-53946.04	Upgrade
EPS (Diluted)	-4.24	-11.58	-16.64	-27.89	-123.99	-1304.05	-6169.41	-9595.20	-15517.24	-53946.04	Upgrade
Free Cash Flow	-13.01	-13.48	-10.36	-8.53	-5.97	-12.11	-18.31	-19.47	-21.07	-31.02	Upgrade
Free Cash Flow Per Share	-4.14	-7.70	-12.85	-28.87	-64.70	-1044.17	-4237.64	-8440.52	-16825.37	-43127.64	Upgrade
Gross Margin	100.00%	100.00%	-	100.00%	100.00%	100.00%	79.44%	80.93%	72.67%	61.31%	Upgrade
Operating Margin	-271.14%	-8800.00%	-	-3163.04%	-52.26%	-293.73%	-303.51%	-168.37%	-196.88%	-431.77%	Upgrade
Profit Margin	-271.04%	-9051.34%	-	-2719.80%	-163.49%	-506.91%	-415.89%	-193.73%	-166.44%	-507.20%	Upgrade
Free Cash Flow Margin	-264.83%	-6018.30%	-	-2814.19%	-85.35%	-405.90%	-285.60%	-171.08%	-180.70%	-408.24%	Upgrade
EBITDA	-12.18	-18.85	-12.05	-6.77	-8.12	-8.71	-18.49	-18.27	-14.27	-32.22	Upgrade
EBITDA Margin	-247.83%	-8416.07%	-	-2232.67%	-116.09%	-291.92%	-288.35%	-160.56%	-122.41%	-424.03%	Upgrade
Depreciation & Amortization	0.75	0.71	0.42	0.37	0.91	2	2.15	1.18	1.09	0.78	Upgrade
EBIT	-12.92	-19.56	-12.47	-7.13	-9.03	-10.71	-20.64	-19.45	-15.37	-33	Upgrade
EBIT Margin	-263.00%	-8733.93%	-	-2354.46%	-129.07%	-359.10%	-321.90%	-170.95%	-131.79%	-434.29%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).